开云app官网登录入口网页版-官方正版

#征求意见#

96篇内容 | 1746人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1949978, encodeId=fe5519499e86a, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=终于来了！《药物真实世界研究设计与方案框架指导原则（征求意见稿）》, objectType=article, longId=731597, objectId=3bace315978b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bace315978b, replyNumber=0, likeNumber=80, createdTime=2023-03-03, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bace315978b, moduleTitle=终于来了！《药物真实世界研究设计与方案框架指导原则（征求意见稿）》, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3bace315978b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949979, encodeId=73c919499e982, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=CDE「以患者为中心」临床指导原则3连发（征求意见稿）, objectType=article, longId=735490, objectId=6af7e354909c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6af7e354909c, replyNumber=0, likeNumber=76, createdTime=2023-04-10, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6af7e354909c, moduleTitle=CDE「以患者为中心」临床指导原则3连发（征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6af7e354909c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949977, encodeId=33fd19499e71b, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=中华人民共和国药品管理法实施条例（修订草案征求意见稿）, objectType=article, longId=726557, objectId=2046e2655796, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2046e2655796, replyNumber=0, likeNumber=63, createdTime=2022-11-28, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2046e2655796, moduleTitle=中华人民共和国药品管理法实施条例（修订草案征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2046e2655796)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949975, encodeId=336919499e51c, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=人类遗传资源管理条例实施细则（征求意见稿）, objectType=article, longId=301419, objectId=04ca3014196b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04ca3014196b, replyNumber=0, likeNumber=69, createdTime=2023-01-27, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04ca3014196b, moduleTitle=人类遗传资源管理条例实施细则（征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=04ca3014196b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949972, encodeId=335a19499e2b7, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=CDE公开征求《人源性干细胞产品药学研究与评价技术指导原则（征求意见稿）》意见, objectType=article, longId=215890, objectId=5635215890ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5635215890ef, replyNumber=0, likeNumber=84, createdTime=2021-09-13, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5635215890ef, moduleTitle=CDE公开征求《人源性干细胞产品药学研究与评价技术指导原则（征求意见稿）》意见, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5635215890ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949976, encodeId=d95819499e677, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=罕见病新药7年市场独占权，中华人民共和国药品管理法实施条例（修订草案征求意见稿）发布, objectType=article, longId=726556, objectId=8f3ce26556ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f3ce26556ea, replyNumber=0, likeNumber=79, createdTime=2022-05-20, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f3ce26556ea, moduleTitle=罕见病新药7年市场独占权，中华人民共和国药品管理法实施条例（修订草案征求意见稿）发布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8f3ce26556ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949974, encodeId=052919499e4d4, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=“干细胞研究与器官修复” 重点专项2022 年度项目申报指南（征求意见稿）, objectType=article, longId=295441, objectId=c2a729544118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2a729544118, replyNumber=0, likeNumber=102, createdTime=2022-09-26, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2a729544118, moduleTitle=“干细胞研究与器官修复” 重点专项2022 年度项目申报指南（征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c2a729544118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949971, encodeId=0cfe19499e1ef, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=中华人民共和国实验动物管理条例（修订草案征求意见稿）, objectType=article, longId=215404, objectId=d94921540410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d94921540410, replyNumber=0, likeNumber=49, createdTime=2021-11-30, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d94921540410, moduleTitle=中华人民共和国实验动物管理条例（修订草案征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d94921540410)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949973, encodeId=7ae519499e3f8, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=CDE发布《药物临床试验中心化监查统计指导原则（征求意见稿）》公开征求意见通知, objectType=article, longId=217255, objectId=cbb821e255b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbb821e255b0, replyNumber=0, likeNumber=69, createdTime=2022-03-09, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbb821e255b0, moduleTitle=CDE发布《药物临床试验中心化监查统计指导原则（征求意见稿）》公开征求意见通知, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cbb821e255b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949967, encodeId=f306194996efc, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=指南解读：涉及人的生命科学和医学研究伦理审查办法（征求意见稿）, objectType=article, longId=208529, objectId=00b920852934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00b920852934, replyNumber=0, likeNumber=60, createdTime=2021-09-04, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00b920852934, moduleTitle=指南解读：涉及人的生命科学和医学研究伦理审查办法（征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=00b920852934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949970, encodeId=cb2619499e0ba, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=长处方征求意见：8类药物被排除，4种情况终止, objectType=article, longId=209508, objectId=fc21209508f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc21209508f0, replyNumber=0, likeNumber=74, createdTime=2021-10-22, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc21209508f0, moduleTitle=长处方征求意见：8类药物被排除，4种情况终止, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fc21209508f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949963, encodeId=43cf1949963b7, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=CDE发布：药物临床试验适应性设计指导原则（征求意见稿）, objectType=article, longId=204258, objectId=620020425818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=620020425818, replyNumber=0, likeNumber=95, createdTime=2021-04-23, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=620020425818, moduleTitle=CDE发布：药物临床试验适应性设计指导原则（征求意见稿）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=620020425818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949964, encodeId=9b0a1949964ac, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=国家药监局公开征求《药物警戒质量管理规范（征求意见稿）》意见, objectType=article, longId=204272, objectId=53412042e256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53412042e256, replyNumber=0, likeNumber=73, createdTime=2021-05-29, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53412042e256, moduleTitle=国家药监局公开征求《药物警戒质量管理规范（征求意见稿）》意见, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=53412042e256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949966, encodeId=ad83194996676, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=《医疗保障行政处罚程序暂行规定（征求意见稿）》发布, objectType=article, longId=205257, objectId=d30320525eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d30320525eb9, replyNumber=0, likeNumber=60, createdTime=2021-05-30, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d30320525eb9, moduleTitle=《医疗保障行政处罚程序暂行规定（征求意见稿）》发布, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d30320525eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949955, encodeId=c08419499554f, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=产生真实世界证据的真实世界数据指导原则征求意见稿来啦！, objectType=article, longId=198664, objectId=293c198664f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293c198664f0, replyNumber=0, likeNumber=78, createdTime=2021-04-05, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293c198664f0, moduleTitle=产生真实世界证据的真实世界数据指导原则征求意见稿来啦！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=293c198664f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949959, encodeId=1044194995976, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=《药品专利纠纷早期解决机制实施办法（试行）》公开征求意见, objectType=article, longId=200684, objectId=bd9b20068447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd9b20068447, replyNumber=0, likeNumber=0, createdTime=2020-11-21, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd9b20068447, moduleTitle=《药品专利纠纷早期解决机制实施办法（试行）》公开征求意见, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bd9b20068447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949969, encodeId=bede19499692d, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=国家卫健委发布《涉及人的生命科学和医学研究伦理审查办法（征求意见稿）》, objectType=article, longId=209503, objectId=5cf12095037d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cf12095037d, replyNumber=0, likeNumber=88, createdTime=2021-11-08, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cf12095037d, moduleTitle=国家卫健委发布《涉及人的生命科学和医学研究伦理审查办法（征求意见稿）》, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5cf12095037d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949960, encodeId=3bef194996048, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=CDE发布《基因治疗产品药学研究与评价技术指导原则（征求意见稿）》, objectType=article, longId=200722, objectId=ba17200e22cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba17200e22cb, replyNumber=0, likeNumber=104, createdTime=2021-02-06, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba17200e22cb, moduleTitle=CDE发布《基因治疗产品药学研究与评价技术指导原则（征求意见稿）》, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ba17200e22cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949956, encodeId=42001949956f0, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=刚刚，国家医保局发布《2020年国家医保药品目录调整工作方案（征求意见稿）》, objectType=article, longId=198689, objectId=88781986891f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88781986891f, replyNumber=0, likeNumber=78, createdTime=2021-04-12, rootId=0, userName=zhaohui6731, userId=bf3d82, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88781986891f, moduleTitle=刚刚，国家医保局发布《2020年国家医保药品目录调整工作方案（征求意见稿）》, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=88781986891f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949954, encodeId=b0831949954c7, content=<a href='/topic/show?id=f8c0503517b' target=_blank style='color:#2F92EE;'>#征求意见#</a>, objectTitle=重疾险疾病定义使用规范再征求意见：将建立重大疾病分级体系, objectType=article, longId=195198, objectId=0ded19519892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ded19519892, replyNumber=0, likeNumber=62, createdTime=2020-08-03, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ded19519892, moduleTitle=重疾险疾病定义使用规范再征求意见：将建立重大疾病分级体系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0ded19519892)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

征求意见

2020-05-29

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

终于来了！《药物真实世界研究设计与方案框架指导原则（征求意见稿）》

2023-03-03

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

CDE「以患者为中心」临床指导原则3连发（征求意见稿）

2023-04-10

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

中华人民共和国药品管理法实施条例（修订草案征求意见稿）

2022-11-28

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

人类遗传资源管理条例实施细则（征求意见稿）

2023-01-27

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

CDE公开征求《人源性干细胞产品药学研究与评价技术指导原则（征求意见稿）》意见

2021-09-13

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

罕见病新药7年市场独占权，中华人民共和国药品管理法实施条例（修订草案征求意见稿）发布

2022-05-20

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

“干细胞研究与器官修复” 重点专项2022 年度项目申报指南（征求意见稿）

2022-09-26

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

中华人民共和国实验动物管理条例（修订草案征求意见稿）

2021-11-30

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

CDE发布《药物临床试验中心化监查统计指导原则（征求意见稿）》公开征求意见通知

2022-03-09

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

指南解读：涉及人的生命科学和医学研究伦理审查办法（征求意见稿）

2021-09-04

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

长处方征求意见：8类药物被排除，4种情况终止

2021-10-22

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

CDE发布：药物临床试验适应性设计指导原则（征求意见稿）

2021-04-23

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

国家药监局公开征求《药物警戒质量管理规范（征求意见稿）》意见

2021-05-29

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

《医疗保障行政处罚程序暂行规定（征求意见稿）》发布

2021-05-30

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

产生真实世界证据的真实世界数据指导原则征求意见稿来啦！

2021-04-05

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

《药品专利纠纷早期解决机制实施办法（试行）》公开征求意见

2020-11-21

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

国家卫健委发布《涉及人的生命科学和医学研究伦理审查办法（征求意见稿）》

2021-11-08

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

CDE发布《基因治疗产品药学研究与评价技术指导原则（征求意见稿）》

2021-02-06

zhaohui6731 (审核中...)

前往app查看评论内容

#征求意见#

刚刚，国家医保局发布《2020年国家医保药品目录调整工作方案（征求意见稿）》

2021-04-12

仁医06 (审核中...)

前往app查看评论内容

#征求意见#

重疾险疾病定义使用规范再征求意见：将建立重大疾病分级体系

2020-08-03

科室
- - 订阅+
  - 更多科室
工具
服务